Please use this identifier to cite or link to this item:
Title: Structural studies with novel ruthenium anticancer agents.
Authors: Soon, Cin Huang.
Keywords: DRNTU::Science::Biological sciences::Biochemistry
Issue Date: 2010
Abstract: In this study, we aim to obtain the crystal structure of the ruthenium based anticancer agents which will provide us a better understand on the drug’s mechanism of action. Two ruthenium based drugs, RuCl2(η6-p-cymene)-(PTA), (PTA = 1,3,5-triaza-7-phosphaadamantane) or RAPTA-C and Hind[trans-RuCl4(ind)2] (ind = indazole) or KP1019 were chosen to react with different DNA oligonucleotides. Weak non-covalent binding of RAPTA-C towards the DNA oligonucleotides is observed. KP1019 shows a tendency for stronger covalent binding towards the DNA oligonucleotides but requires high drug to DNA molar ratios. Due to its transient binding, RAPTA-C is not suitable for use in crystallizations. Crystals of the KP1019 adducted oligonucleotides could not be obtained from the condition that gave crystals for unadducted oligonucleotides. Hence, more screens are needed to obtain optimized conditions for the growth of KP1019-derivirtized oligonucleotides.
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
  Restricted Access
1.31 MBAdobe PDFView/Open

Page view(s)

checked on Sep 30, 2020


checked on Sep 30, 2020

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.